STOICA & ASOCIAȚII obține în instanță, pentru o importantă companie farmaceutică, dreptul de a continua comercializarea suplimentelor alimentare cu albastru de metilen

STOICA & ASOCIAȚII secured a court ruling allowing Terapia S.A. to continue selling food supplements containing methylene blue, suspending INSP's cancellation of their notification certificates. The court's decision prevents the halt of sales worth over 60 million lei in a market exceeding 200 million lei. INSP's cancellation was based on a 2025 alert regarding methylene blue's EU authorization status, which was not linked to Terapia S.A.'s products. The ruling highlights inconsistencies in regulatory actions, as methylene blue has a long history of use and other products remain unaffected.